
- Volume 0 0
Mallinckrodt Teams with Zydus
Mallinckrodt Pharmaceuticals Genericshas entered into a strategicalliance with Zydus Cadila's US subsidiary,Zydus Pharmaceuticals Inc.The agreement calls for MallinckrodtPharmaceuticals Generics to marketand sell products under a sharedMallinckrodt-Zypharma label. Theproducts will be developed and registeredby Zydus Pharmaceuticals andwill be manufactured by Zydus Cadilaat its US FDA-approved manufacturingplant in Ahmedabad, India.
By melding Mallinckrodt's marketingand distribution networks withZydus Cadila's product developmentand manufacturing success, Mallinckrodtexpands its product portfolio andpipeline.
Articles in this issue
about 21 years ago
Internet Prescribing 2005about 21 years ago
COMPOUNDING HOTLINEabout 21 years ago
Breakfast Cereals Take a Step in the Right Directionabout 21 years ago
Refined Carbs Cause Obesityabout 21 years ago
Obesity Problematic for Young Transplant Patientsabout 21 years ago
High BMI Linked to Dementiaabout 21 years ago
When Does Compounding Become Manufacturing?about 21 years ago
Talking to Your Diabetes Patients About Fiberabout 21 years ago
Counseling Guide for Avoiding Asthma Triggersabout 21 years ago
RA Drug Does Not Alter Cholesterol Ratio







































































































































